awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33680393-303B4EE2-58EC-4686-88B0-EF9839D29646
Q33680393-303B4EE2-58EC-4686-88B0-EF9839D29646
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33680393-303B4EE2-58EC-4686-88B0-EF9839D29646
Cost effectiveness of TAC versus FAC in adjuvant treatment of node-positive breast cancer.
P2860
Q33680393-303B4EE2-58EC-4686-88B0-EF9839D29646
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33680393-303B4EE2-58EC-4686-88B0-EF9839D29646
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
65fda70ccc81c3de9f47d306a83078ddd4b8c881
P2860
Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colo